NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $385,846 | +0.9% | 3,788 | 0.0% | 0.16% | -2.4% |
| Q2 2023 | $382,247 | +9.7% | 3,788 | 0.0% | 0.16% | 0.0% |
| Q1 2023 | $348,496 | +1.4% | 3,788 | 0.0% | 0.16% | +0.6% |
| Q4 2022 | $343,647 | +19.3% | 3,788 | 0.0% | 0.16% | +0.6% |
| Q3 2022 | $288,000 | -41.1% | 3,788 | -34.6% | 0.16% | -39.4% |
| Q2 2022 | $489,000 | -3.7% | 5,788 | 0.0% | 0.27% | +19.0% |
| Q1 2022 | $508,000 | +0.4% | 5,788 | 0.0% | 0.23% | -13.1% |
| Q4 2021 | $506,000 | -10.8% | 5,788 | -3.5% | 0.26% | -23.1% |
| Q4 2020 | $567,000 | -88.2% | 6,000 | -89.4% | 0.34% | -78.6% |
| Q1 2014 | $4,822,000 | -44.4% | 56,713 | -47.4% | 1.58% | -44.6% |
| Q4 2013 | $8,674,000 | +3.7% | 107,916 | -1.0% | 2.84% | -2.9% |
| Q3 2013 | $8,365,000 | +7.5% | 109,043 | -0.9% | 2.93% | +2.1% |
| Q2 2013 | $7,782,000 | – | 110,058 | – | 2.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |